IE831277L - Benzhydrylsulphinylacetamide derivatives. - Google Patents
Benzhydrylsulphinylacetamide derivatives.Info
- Publication number
- IE831277L IE831277L IE831277A IE127783A IE831277L IE 831277 L IE831277 L IE 831277L IE 831277 A IE831277 A IE 831277A IE 127783 A IE127783 A IE 127783A IE 831277 L IE831277 L IE 831277L
- Authority
- IE
- Ireland
- Prior art keywords
- represent
- general formula
- derivative
- different
- see diagramm
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
- C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
- C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/18—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
- C07C33/24—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part polycyclic without condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
For the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE 1. A novel benzhydrylsulfinylacetamide derivative characterized in that it is selected from the group consisting of compounds of the general formula : see diagramm : EP0097071,P21,F1 wherein - X1 and X2 , which may be identical or different each represent H, Cl or F, - Z1 represents CH3 , CH2 CH3 , CH(CH3 )2 or C(CH3 )3 , Z1 may represent the hydrogen atom when at least one of X1 and X2 is different from H, - Z2 represents H ; NZ1 Z2 considered together may represent a piperidino or morpholino group. For the contracting state AT 1. A method for the preparation of a novel benzhydrylsulfinylacetamide derivative of the general formula : see diagramm : EP0097071,P22,F1 wherein : - X1 and X2 which may be identical or different each represent H, Cl or F, - Z1 represents CH3 , CH2 CH3 , CH(CH3 )2 or C(CH3 )3 , Z1 may represent the hydrogen atom when at least one of X1 and X2 is different from H, - Z2 represents H ; NZ1 Z2 considered together may represent a piperidino or morpholino group, characterized in that an acid chloride of general formula see diagramm : EP0097071,P22,F2 wherein X1 and X2 are as defined above, is reacted with an amine of general formula HNZ1 Z2 wherein Z1 and Z2 have the above definition, to a benzhydrythiocetamide derivative of general formula see diagramm : EP0097071,P22,F3 wherein X1 , X2 , Z1 and Z2 are as defined above, and the obtained benzhydrylthiocetamide derivative of formula (IV) is oxidized.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8209802A FR2528038B2 (en) | 1982-06-04 | 1982-06-04 | BENZHYDRYLSULFINYLACETAMIDE DERIVATIVES AND THEIR THERAPEUTIC USE |
Publications (2)
Publication Number | Publication Date |
---|---|
IE831277L true IE831277L (en) | 1983-12-04 |
IE54988B1 IE54988B1 (en) | 1990-04-11 |
Family
ID=9274663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE1277/83A IE54988B1 (en) | 1982-06-04 | 1983-05-30 | Benzhydrylsulfinylacetamide derivatives |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0097071B1 (en) |
JP (1) | JPS591459A (en) |
AT (1) | ATE15185T1 (en) |
CA (1) | CA1199916A (en) |
DE (1) | DE3360668D1 (en) |
DK (1) | DK158039C (en) |
ES (1) | ES8403445A1 (en) |
FR (1) | FR2528038B2 (en) |
IE (1) | IE54988B1 (en) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6196949A (en) * | 1984-10-18 | 1986-05-15 | Nisshin Oil Mills Ltd:The | Production of food like snack |
FR2584666B1 (en) * | 1985-07-10 | 1989-06-16 | Champion Spark Plug Europ | MOTOR ARM FOR WIPER BLADE WITH SLIDING CAP |
FR2593809B1 (en) * | 1986-01-31 | 1988-07-22 | Lafon Labor | BENZHYDRYLSULFINYLACETAMIDE, PROCESS FOR PREPARATION AND THERAPEUTIC USE |
GB8610911D0 (en) * | 1986-05-03 | 1986-06-11 | Beecham Group Plc | Active compounds |
FR2602768B1 (en) * | 1986-08-13 | 1989-02-03 | Lafon Labor | 2- (4,4'-DIFLUORO BENZHYDRYL THIO) ACETIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC APPLICATIONS |
FR2606015B1 (en) * | 1986-08-13 | 1989-05-19 | Lafon Labor | BENZHYDRYLTHIOMETHANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC APPLICATIONS |
IT1238489B (en) * | 1990-02-08 | 1993-08-18 | Mario Nobile Caprile | BATTERY CHARGING DEVICE |
FR2707637B1 (en) * | 1993-06-30 | 1995-10-06 | Lafon Labor | New acetamide derivatives, their preparation process and their use in therapy. |
FR2708201B1 (en) * | 1993-06-30 | 1995-10-20 | Lafon Labor | Use of acetamide derivatives for the manufacture of medicaments. |
US6492396B2 (en) * | 2000-05-16 | 2002-12-10 | Cephalon, Inc. | Substituted thioacetamides |
IL143106A (en) * | 2001-05-13 | 2005-11-20 | Chemagis Ltd | Process for the preparation of diphenylmethylthioacetamide |
US20040048931A1 (en) | 2002-07-12 | 2004-03-11 | Craig Heacock | Modafinil pharmaceutical compositions |
EP1437345A1 (en) * | 2003-01-13 | 2004-07-14 | Organisation de Synthese Mondiale Orsymonde | Novel method for preparing methyl 2-diphenylmethylsulfinylacetate |
EP1603867A2 (en) | 2003-02-24 | 2005-12-14 | Mallinckrodt Inc. | Process for preparing benzhydrylthioacetamide |
EP1516869A1 (en) * | 2003-09-19 | 2005-03-23 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
US7368591B2 (en) | 2003-09-19 | 2008-05-06 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
US7314875B2 (en) | 2004-04-13 | 2008-01-01 | Cephalon, Inc. | Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
FR2970711B1 (en) | 2011-01-20 | 2016-03-04 | Hopitaux Paris Assist Publique | LAUFLUMIDE AND ITS ENANTIOMERS, PREPARATION AND THERAPEUTIC USES |
WO2014037832A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment of epilepsy and neurological diseases |
WO2013167990A1 (en) | 2012-05-07 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of depression |
CN104603096A (en) | 2012-05-07 | 2015-05-06 | 塞利克斯比奥私人有限公司 | Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders |
JP2015519333A (en) | 2012-05-07 | 2015-07-09 | セリックスビオ プライヴェート リミテッド | Compositions and methods for the treatment of neurological disorders |
US9266823B2 (en) | 2012-05-08 | 2016-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of parkinson's disease |
US9434704B2 (en) | 2012-05-08 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological degenerative disorders |
US9309233B2 (en) | 2012-05-08 | 2016-04-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of blood clotting disorders |
US9522884B2 (en) | 2012-05-08 | 2016-12-20 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic disorders |
US9403826B2 (en) | 2012-05-08 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory disorders |
US9242939B2 (en) | 2012-05-10 | 2016-01-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
WO2013167997A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
US9346742B2 (en) | 2012-05-10 | 2016-05-24 | Cellix Bio Private Limited | Compositions and methods for the treatment of fibromyalgia pain |
WO2013179153A1 (en) * | 2012-05-10 | 2013-12-05 | Mahesh Kandula | Compositions and methods for treatment of neurological degenerative disorders and neurological diseases |
WO2013168000A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of severe pain |
WO2013168005A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
WO2013168011A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of chronic pain |
WO2013168016A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
US9499527B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of familial amyloid polyneuropathy |
WO2013167999A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurologic diseases |
WO2013168002A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurological conditions |
US9499526B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
WO2013168015A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of asthma and allergy |
US9321775B2 (en) | 2012-05-10 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
US9492409B2 (en) | 2012-05-23 | 2016-11-15 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
WO2013175347A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of respiratory disorders |
US9434729B2 (en) | 2012-05-23 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
WO2013175377A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
WO2013175357A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of inflammatory bowel disease |
US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
WO2014020480A2 (en) | 2012-08-03 | 2014-02-06 | Mahesh Kandula | Compositions and methods for the treatment migraine and neurologic diseases |
WO2014037833A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment inflammation and lipid disorders |
EP2892878A4 (en) | 2012-09-08 | 2016-02-24 | Cellix Bio Private Ltd | Compositions and methods for the treatment of inflammation and lipid disorders |
EP2964611B1 (en) | 2013-03-08 | 2022-10-19 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Potent and selective inhibitors of monoamine transporters; method of making; and use thereof |
CN104341327A (en) * | 2013-08-08 | 2015-02-11 | 中国人民解放军63975部队 | Multi-halogen substituted 2-(diphenylmethyl sulfinyl)acetamide compounds and stereoisomers thereof |
US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
CN104045588A (en) * | 2014-06-11 | 2014-09-17 | 江苏斯威森生物医药工程研究中心有限公司 | Synthetic method of 2-(4,4'-dihalogeno-diphenylmethylsulfinyl)acetamide |
WO2016046835A1 (en) | 2014-09-26 | 2016-03-31 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological disorders |
AU2014407862B2 (en) | 2014-09-29 | 2020-03-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
CN107108535B (en) | 2014-10-27 | 2020-04-28 | 塞尔利克斯生物私人有限公司 | Three-component salts of monomethyl fumarate with piperazine or ethylenediamine for the treatment of multiple sclerosis |
US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
EP3242869B1 (en) | 2015-01-06 | 2021-10-27 | Cellixbio Private Limited | Compositions and methods for the treatment of inflammation and pain |
US11365195B2 (en) | 2017-11-13 | 2022-06-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Atypical inhibitors of monoamine transporters; method of making; and use thereof |
KR102126389B1 (en) * | 2018-09-14 | 2020-06-25 | 셀라이온바이오메드 주식회사 | A composition for preventing or treating liver diseases comprising benzhydrylthio acetamide derivative as an active ingredient |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1584462A (en) * | 1977-03-31 | 1981-02-11 | Lafon Labor | N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them |
-
1982
- 1982-06-04 FR FR8209802A patent/FR2528038B2/en not_active Expired
-
1983
- 1983-05-26 DE DE8383401046T patent/DE3360668D1/en not_active Expired
- 1983-05-26 EP EP83401046A patent/EP0097071B1/en not_active Expired
- 1983-05-26 AT AT83401046T patent/ATE15185T1/en not_active IP Right Cessation
- 1983-05-30 IE IE1277/83A patent/IE54988B1/en not_active IP Right Cessation
- 1983-05-31 CA CA000429261A patent/CA1199916A/en not_active Expired
- 1983-06-03 ES ES522981A patent/ES8403445A1/en not_active Expired
- 1983-06-03 DK DK253583A patent/DK158039C/en not_active IP Right Cessation
- 1983-06-04 JP JP58098798A patent/JPS591459A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JPS591459A (en) | 1984-01-06 |
ES522981A0 (en) | 1984-03-16 |
DK253583A (en) | 1983-12-05 |
IE54988B1 (en) | 1990-04-11 |
DK158039B (en) | 1990-03-19 |
FR2528038A2 (en) | 1983-12-09 |
EP0097071A1 (en) | 1983-12-28 |
DE3360668D1 (en) | 1985-10-03 |
EP0097071B1 (en) | 1985-08-28 |
ES8403445A1 (en) | 1984-03-16 |
CA1199916A (en) | 1986-01-28 |
FR2528038B2 (en) | 1985-08-09 |
DK158039C (en) | 1990-08-13 |
DK253583D0 (en) | 1983-06-03 |
ATE15185T1 (en) | 1985-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE831277L (en) | Benzhydrylsulphinylacetamide derivatives. | |
YU295280A (en) | Process for the manufacturin of acyl derivatives | |
DE69111412D1 (en) | Process for the selective flotation of metal ores with 2-mercaptothiazole derivatives. | |
GB2017087A (en) | Process for the preparation of xanthone derivatives | |
NO832667L (en) | PROCEDURE FOR PREPARING 7ALFA-ACYLTHIO-15,16-METHYLENE-3-OXO-17ALFA-PREGNA-1,4-DIEN-21,17-CARBOLACTONES | |
ATE12039T1 (en) | SUBSTITUTED AZOLYL GLYCOLSULFONATES, FUNGICIDES CONTAINING THEM AND PROCESS FOR THEIR PRODUCTION. | |
ATE1582T1 (en) | PROCESSES AND INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF 2-BENZAZEPINE DERIVATIVES. | |
AU580179B2 (en) | Substituted phenylpiperazine derivatives | |
ATE135693T1 (en) | HALOGENO-4-METHYLPYRAZOLES AND METHOD FOR THE PRODUCTION THEREOF | |
ATE6151T1 (en) | N-ARYL-N'-ACRYLOYL-UREIDES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MICROBICIDES. | |
DE3267690D1 (en) | Process for the preparation of 3-alkyl-6-methyl-beta-resorcylic-acid esters | |
DE2962254D1 (en) | 7a-methyl estrogens and process for their preparation and their use in further processing | |
ES8303400A1 (en) | Benzylazole derivatives. | |
DE3460123D1 (en) | Phosphonic acid esters | |
ATE47860T1 (en) | PHOSPPHINE ACID ADDUCT TO HALF-MALEIC ACID, PROCESS FOR THEIR PREPARATION AND USE. | |
ATE39484T1 (en) | AZOLYL ETHER, PROCESS OF PRODUCTION AND THEIR USE AS FUNGICIDES. | |
DE3060348D1 (en) | Process for the preparation of xanthone derivatives | |
DE2961162D1 (en) | 7-alpha-methyl-estrogens, process for their preparation and their use in further processing | |
SE7900889L (en) | WAY TO PRODUCE XANTONE DERIVATIVES | |
ATE16386T1 (en) | TRIAZOLE COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND FUNGICIDES CONTAINING THEM. | |
ATE50569T1 (en) | ALPHA-ALLYLATED ARYLALKYLTRIAZOLES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS FUNGICIDES. | |
TH808EX (en) | New indolicine derivatives And the process for preparing this derivative | |
ES478144A1 (en) | A procedure for the production of nitrogenated heterociclic compounds. (Machine-translation by Google Translate, not legally binding) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK9A | Patent expired |